Results 131 to 140 of about 7,225 (173)

Case Report: Successful treatment of pyoderma gangrenosum-like granulomatous liver disease without skin lesions using a TNF-alpha inhibitor. [PDF]

open access: yesFront Immunol
Panne I   +11 more
europepmc   +1 more source

Determining Progression in Ectatic Corneal Disease

open access: yesAsia-Pacific Journal of Ophthalmology, 2020
Before the advent of modern tomographic imaging and corneal cross-linking (CXL), diagnosis and treatment of ectatic disease were limited to disease severity where changes on the anterior corneal surface lead to visual complaints. Rigid contact lenses and/or penetrating keratoplasty addressed late stage disease, as identifying early or subclinical ...
Renato Ambrosio   +2 more
exaly   +4 more sources

Ectatic diseases

Experimental Eye Research, 2021
Ectatic corneal disease (ECD) comprises a group of disorders characterized by progressive thinning and subsequent bulging of the corneal structure. Different phenotypes have been recognized, including keratoglobus, pellucid marginal degeneration (PMD), and keratoconus (KC).
Renato Ambrosio   +2 more
exaly   +3 more sources

Keratoconus and Ectatic Disease: Evolving Criteria for Diagnosis [PDF]

open access: yesKlinische Monatsblatter Fur Augenheilkunde, 2020
AbstractThe approach to corneal ectatic disease has changed dramatically over the last decade with advances in both diagnosis and treatment. Newer treatments, such as corneal cross-linking, have the potential to slow or stop the progression of the disease, but benefit from earlier identification of the disease than had previously been possible or ...
exaly   +3 more sources

New Diagnostics in Corneal Ectatic Disease

International Ophthalmology Clinics, 2017
Mitchell Weikert
exaly   +3 more sources

Home - About - Disclaimer - Privacy